Cargando…

Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study

OBJECTIVE: This double-blind, placebo-controlled comparative study was designed to investigate whether pranlukast dry syrup, a leukotriene receptor antagonist, has a protective effect against priming, controlled pollen exposure, and natural pollen exposure in children with Japanese cedar pollinosis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosoya, Kei, Masuno, Satoru, Hashiguchi, Kazuhiro, Okubo, Kimihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937631/ https://www.ncbi.nlm.nih.gov/pubmed/27536454 http://dx.doi.org/10.3109/21556660.2014.960969

Ejemplares similares

Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamber
por: Endo, Shuichiro, et al.
Publicado: (2012)

Evaluation of Montelukast for the Treatment of Children With Japanese Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO Chamber)
por: Hashiguchi, Kazuhiro, et al.
Publicado: (2018)

The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber
por: Hashiguchi, Kazuhiro, et al.
Publicado: (2012)

Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber
por: Hashiguchi, Kazuhiro, et al.
Publicado: (2013)

Microarray-Based Multivariate Analysis of the Effectiveness of Sublingual Immunotherapy for Cedar Pollinosis
por: Gotoh, Minoru, et al.
Publicado: (2018)

Are respiratory viruses involved in preseasonal symptoms or severity in Japanese cedar pollinosis?
por: Otsuka, Hirokuni, et al.
Publicado: (2016)

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
por: Kurokawa, Tomoya, et al.
Publicado: (2022)

Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy
por: Otsuka, Kuninori, et al.
Publicado: (2020)

180 Selecting Primal Therapy Appropriate for the Type of Pollinosis—Topic-J Study
por: Okubo, Kimihiro, et al.
Publicado: (2012)

Asthma in Patients With Japanese Cedar Pollinosis
por: Tanaka, Akihiko, et al.
Publicado: (2012)

Minimal persistent inflammation in Japanese cedar pollinosis and a prophylactic effect of intranasal corticosteroids
por: Noyama, Yasuyuki, et al.
Publicado: (2013)

Determining an Appropriate Time to Start Prophylactic Treatment with Intranasal Corticosteroids in Japanese Cedar Pollinosis
por: Haruna, Takenori, et al.
Publicado: (2019)

Allergen‐specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season
por: Otsuka, Kuninori, et al.
Publicado: (2020)

Japanese cedar pollinosis: Discovery, nomenclature, and epidemiological trends
por: SAITO, Yozo
Publicado: (2014)

Japanese Cedar (Cryptomeria japonica) Pollinosis in Jeju, Korea: Is It Increasing?
por: Lee, Jaechun, et al.
Publicado: (2015)

Sublingual Immunotherapy for Japanese Cedar Pollinosis Attenuates Asthma Exacerbation
por: Kikkawa, Sayaka, et al.
Publicado: (2019)

Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis
por: Kong, Qingliang, et al.
Publicado: (2020)

Staphylococcus aureus nasal colonization increases the risk of cedar pollinosis
por: Morizane, Atsushi, et al.
Publicado: (2022)

Anti-inflammatory roles of interleukin-35 in the pathogenesis of Japanese cedar pollinosis
por: Kouzaki, Hideaki, et al.
Publicado: (2021)

Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status
por: Sakurai, Daiju, et al.
Publicado: (2022)

Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure
por: Kanzaki, Sho, et al.
Publicado: (2016)

Cedar Pollinosis and Mortality: A Population-Based Prospective Cohort Study in Japan
por: Mori, Kenichi, et al.
Publicado: (2019)

572 Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis
por: Tanaka, Toshio, et al.
Publicado: (2012)

Effect of Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis and regulatory T cells in adults
por: Suzuki, Shuichi, et al.
Publicado: (2019)

Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches
por: Takaiwa, Fumio
Publicado: (2021)

The Combined Effects of Sublingual Immunotherapy and Lactobacillus acidophilus-Producing Extract on Cedar Pollinosis Symptoms
por: Hirobumi, Ito, et al.
Publicado: (2023)

Beneficial Effects of Citrus Juice Fermented with Lactobacillus plantarum YIT 0132 on Japanese Cedar Pollinosis
por: HARIMA-MIZUSAWA, Naomi, et al.
Publicado: (2014)

A Novel Approach of Preventing Japanese Cedar Pollen Dispersal That Is the Cause of Japanese Cedar Pollinosis (JCP) Using Pollen-Specific Fungal Infection
por: Hirooka, Yuuri, et al.
Publicado: (2013)

Safety and efficacy of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a randomized controlled trial
por: Murakami, Daisuke, et al.
Publicado: (2017)

Early interventional treatment with intranasal corticosteroids is superior to post-onset treatment in Japanese cedar/cypress pollinosis
por: Haruna, Takenori, et al.
Publicado: (2013)

160 Candidate for Response Monitoring or Prognostic Biomarkers in Two-Year Sublingual Immunotherapy for Japanese Cedar Pollinosis
por: Fujimura, Takashi, et al.
Publicado: (2012)

Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis
por: Yoneda, Riyo, et al.
Publicado: (2022)

Leuconostoc mesenteroides subsp. strain NTM048 ameliorated nasal symptoms in patients with Japan cedar pollinosis: Randomized, double-blind, and placebo-controlled trial
por: Yamamoto, Yuta, et al.
Publicado: (2023)

Suppressive Effect of Lactococcus lactis subsp. cremoris YRC3780 on a Murine Model of Japanese Cedar Pollinosis
por: Uchida, Kenji, et al.
Publicado: (2022)

Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Efficacy and Safety of Modified Pranlukast (Prakanon(®)) Compared with Pranlukast (Onon(®)): A Randomized, Open-Label, Crossover Study
por: Kim, Seo W., et al.
Publicado: (2016)

A Case of Pranlukast-Induced Anaphylactic Shock
por: Kim, Sujeong, et al.
Publicado: (2016)

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022)

Effects of citrus juice fermented with Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis during probiotic consumption: an open study
por: KAKIYAMA, Sayaka, et al.
Publicado: (2020)

Intake of a fermented plant product attenuates allergic symptoms without changing systemic immune responses in a mouse model of Japanese cedar pollinosis
por: Fujimura, Takashi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1k6vvu6btppsl77c6k5bvq8s0q